We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Menopausal Status Should Guide Mammography Intervals

By MedImaging International staff writers
Posted on 04 Nov 2015
Print article
A new study suggests that menopause may be a more important indicator than age when determining breast cancer (BC) screening intervals.

Researchers at the University of California Davis (UCD; USA), the University of California, San Francisco (UCSF; USA), and other institutions conducted a prospective cohort study of 15,440 women (40–85 years of age) to compare the proportion of BC with less versus more favorable prognostic characteristics in women screening annually versus biennially by age, menopausal status, and postmenopausal hormone therapy (HT) use. The researchers defined less favorable prognostic characteristics as tumors that were stage IIB or higher, size greater than 15 mm, positive nodes, and any one or more of these characteristics.

The results showed that among 2,027 premenopausal women (13.1%), biennial screeners had a higher proportion of tumors with less favorable prognostic characteristic, compared to annual screeners. Among women taking postmenopausal HT, biennial screeners also tended to have tumors with less favorable prognostic characteristics than annual screeners, but differences were not statistically significant. Postmenopausal women not using HT had a higher proportion of invasive cancers if they were screened biennially than women who were screened annually. The study was published on October 20, 2015, in JAMA Oncology.

“Our findings suggest that menopausal status may be more important than age when considering breast cancer screening intervals,” concluded lead author Diana Miglioretti, PhD, and colleagues. “If screening guidelines were based on menopausal status rather than age, some women ages 40 to 54 years might be recommended for more frequent screening and others, less frequent screening.”

The frequency at which women should receive screening mammography remains controversial in the United States. In 2009, the US Preventive Services Task Force (USPSTF; Rockville, MD, USA) updated breast cancer screening guidelines to recommend routine biennial mammography for women ages 50–74 years, based on evidence suggesting that the harms of more frequent screening outweigh the small estimated added benefit of annual screening. In contrast, the American Cancer Society (ACS) recommends annual screening for women 40 years of age and older.

Related Links:

University of California Davis
University of California, San Francisco
US Preventive Services Task Force


Portable Color Doppler Ultrasound Scanner
DCU10
Portable Color Doppler Ultrasound System
S5000
New
Digital X-Ray Detector Panel
Acuity G4
Ultrasound Imaging System
P12 Elite

Print article

Channels

Ultrasound

view channel
Image: The novel method of fighting cancer can stimulate critical cytokine secretion in T cells

Ultrasound-Directed Microbubbles Boost Immune Response Against Tumors

A significant challenge in cancer treatment is the tumor's ability to suppress the immune system, particularly by deactivating T cells that enter the tumor. Once inside, the tumor can inhibit T cells from... Read more

Nuclear Medicine

view channel
Image: PSMA-PET/CT images of an 85-year-old patient with hormone-sensitive prostate cancer (Photo courtesy of Dr. Adrien Holzgreve)

Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients

Prostate-specific membrane antigen–positron emission tomography (PSMA-PET) imaging has become an essential tool in transforming the way prostate cancer is staged. Using small amounts of radioactive “tracers,”... Read more

General/Advanced Imaging

view channel
Image: Automated methods enable the analysis of PET/CT scans (left) to accurately predict tumor location and size (right) (Photo courtesy of Nature Machine Intelligence, 2024. DOI: 10.1038/s42256-024-00912-9)

Deep Learning Based Algorithms Improve Tumor Detection in PET/CT Scans

Imaging techniques are essential for cancer diagnosis, as accurately determining the location, size, and type of tumors is critical for selecting the appropriate treatment. The key imaging methods include... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.